The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start. The DTCC website is a database that lists the names of […]The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start. The DTCC website is a database that lists the names of […]

Franklin Templeton’s proposed XRP ETF inches closer to approval

The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start.

The DTCC website is a database that lists the names of live exchange-traded funds and those in the pre-launch phase, but it only does so as a formality and does not track the likelihood of approvals ahead of their official market debut.

Franklin Templeton’s XRPZ listed on DTCC post-S-1 filing amendment

Bloomberg ETF analyst James Seyffart had reported on Tuesday that Franklin Templeton submitted an amended Form S-1 registration statement for the XRP fund. The changes made include the shortened “8(a)” language, a legal “loophole” that allows the registration to automatically take effect after 20 days without a direct US Securities and Exchange (SEC) sign-off, unless the agency intervenes.

The updated prospectus sent to the regulator on Tuesday specifies that the Franklin XRP Trust will hold XRP tokens as its primary asset and will track the digital asset’s market performance. Once approved, the ETF is expected to list on the Cboe BZX Exchange.

Franklin Templeton’s filing is among several similar ETF submissions and proposed filing changes made in early November. Bitwise and Canary Capital filed amendments last week, removing the traditional “delaying amendment” clause to limit the SEC’s ability to control the timeline of approval.

Grayscale Investments also lodged its second amendment (Amendment No. 2) to its own XRP-related Form S-1 on Monday. 

Crypto In America podcast host and former FOX News correspondent Eleanor Terrett said Canary Capital could see its XRP ETF approved by November 13, pending final clearance from Nasdaq through its 8-A filing, and whether the government shutdown ends sooner. 

“The government reopening could affect the timing, potentially moving it up if the filing is complete and the SEC is satisfied, or back if staff propose additional comments,” she wrote on X in late October.

The strategy deployed by Franklin Templeton copies that of issuers behind Solana (SOL), Litecoin (LTC), and Hedera (HBAR) ETFs, which successfully launched under similar automatic-effect rules last month.

Just before the 38-day-long and counting US government shutdown began, these ETFs managed to clear the regulatory process and list without formal SEC approval delays. Bitwise’s BSOL ETF recorded an impressive $56 million in first-day trading volume, the highest debut among more than 850 ETFs launched to date.

Franklin Templeton ‘optimistic’ on digital asset market products

Franklin Templeton, the seven-decade-old financial firm that manages over $1.5 trillion in global assets, is among the most active traditional finance entities to launch crypto-based investment vehicles.

Earlier this year, it debuted spot EZBC (Bitcoin) and EZET (Ethereum) funds, which collectively attracted over $500 million in institutional capital within their first quarter. 

The New York-based company has also started a blockchain-based project in Hong Kong, launching the region’s first tokenized money-market fund together with the Hong Kong Monetary Authority (HKMA) under its new Fintech 2030 roadmap.

The Franklin OnChain US Government Money Fund is registered in Luxembourg and backed by short-term US Treasuries, using blockchain tokens in place of investor shares. Working with HSBC and OSL Group, one of Hong Kong’s 11 licensed virtual-asset platforms, Franklin Templeton is testing instant settlements through Project Ensemble, an HKMA sandbox for tokenized deposits. 

HSBC executives believe the tokenized platform could help bump fund flows and improve cross-system interoperability, which could later influence ETF operations in tokenized form. 

XRP ETF crosses $100 million in AUM after weeks of trading

Away from pending ETF approvals, the live REX-Osprey XRP ETF (XRPR), launched on September 18, surpassed $100 million in assets under management (AUM) within just five weeks, according to the issuer’s report in late October.

Outside US markets, the Hashdex Nasdaq XRP ETF (XRPH11), the world’s first spot XRP ETF, listed in Brazil, has accumulated approximately 7.17 billion Brazilian reais (around $1.33 billion) in total assets from over 300,000 investors, per statistics shared by the ETF provider’s website.

Sharpen your strategy with mentorship + daily ideas - 30 days free access to our trading program

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0723
$2.0723$2.0723
-1.15%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26